Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donna L Forrest

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
British Journal of Haematology|May 30, 2012
Allogeneic haematopoietic stem cell transplantation for chronic lymphocytic leukaemia: outcome in a 20-year cohortCynthia L Toze, Chinmay B Dalal, Thomas J Nevill, et al.
Blood Cell Therapy|September 10, 2025
Racial Disparity in Myeloablative Hematopoietic Cell Transplantation Outcomes in Patients with Hematological Malignancies Older Than 45 YearsSatarupa Mohapatra, Yasser R Abou Mourad, Hannah M Cherniawsky, et al.
British Journal of Haematology|May 10, 2018
Excellent real-world outcomes of adults with Burkitt lymphoma treated with CODOX-M/IVAC plus or minus rituximabKatie Y Zhu, Kevin W Song, Joseph M Connors, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 7, 2015
Outcome of Patients With Non-Hodgkin Lymphomas With Concurrent MYC and BCL2 Rearrangements Treated With CODOX-M/IVAC With Rituximab Followed by Hematopoietic Stem Cell TransplantationHaowei Sun, Kerry J Savage, Aly Karsan, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
British Journal of Haematology|May 30, 2012
Allogeneic haematopoietic stem cell transplantation for chronic lymphocytic leukaemia: outcome in a 20-year cohortCynthia L Toze, Chinmay B Dalal, Thomas J Nevill, et al.
Blood Cell Therapy|September 10, 2025
Racial Disparity in Myeloablative Hematopoietic Cell Transplantation Outcomes in Patients with Hematological Malignancies Older Than 45 YearsSatarupa Mohapatra, Yasser R Abou Mourad, Hannah M Cherniawsky, et al.
British Journal of Haematology|May 10, 2018
Excellent real-world outcomes of adults with Burkitt lymphoma treated with CODOX-M/IVAC plus or minus rituximabKatie Y Zhu, Kevin W Song, Joseph M Connors, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 7, 2015
Outcome of Patients With Non-Hodgkin Lymphomas With Concurrent MYC and BCL2 Rearrangements Treated With CODOX-M/IVAC With Rituximab Followed by Hematopoietic Stem Cell TransplantationHaowei Sun, Kerry J Savage, Aly Karsan, et al.
Pageof 5